86,894 Albemarle Corporation $ALB Shares Acquired by Impax Asset Management Group plc

Impax Asset Management Group plc lifted its stake in Albemarle Corporation (NYSE:ALB – Free Report) by 474.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105,219 shares of the specialty chemicals company’s stock after buying an additional 86,894 shares during the period. Impax Asset Management Group plc owned approximately 0.09% of Albemarle worth $11,130,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. Cibc World Market Inc. lifted its position in shares of Albemarle by 715.6% in the third quarter. Cibc World Market Inc. now owns 186,408 shares of the specialty chemicals company’s stock valued at $19,718,000 after buying an additional 163,553 shares during the last quarter. Teachers Retirement System of The State of Kentucky boosted its stake in shares of Albemarle by 325.7% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 39,261 shares of the specialty chemicals company’s stock worth $4,153,000 after acquiring an additional 30,039 shares during the period. HighTower Advisors LLC boosted its stake in shares of Albemarle by 982.2% during the 3rd quarter. HighTower Advisors LLC now owns 234,180 shares of the specialty chemicals company’s stock worth $24,772,000 after acquiring an additional 212,540 shares during the period. Silver Oak Securities Incorporated increased its holdings in shares of Albemarle by 30.8% during the 3rd quarter. Silver Oak Securities Incorporated now owns 2,589 shares of the specialty chemicals company’s stock worth $257,000 after acquiring an additional 609 shares during the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Albemarle by 15,408.6% during the 3rd quarter. Bessemer Group Inc. now owns 358,715 shares of the specialty chemicals company’s stock worth $37,945,000 after acquiring an additional 356,402 shares during the last quarter. 92.87% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have issued reports on ALB shares. Royal Bank Of Canada cut their price target on Albemarle from $129.00 to $119.00 and set an “outperform” rating for the company in a report on Friday, November 6th. Zacks Research raised shares of Albemarle from a “strong sell” rating to a “hold” rating in a research report on Monday, November 9th. Weiss Ratings upgraded shares of Albemarle from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, November 4th. Truist Financial reiterated a “buy” rating and issued a $170.00 price objective (down from $185.00) on shares of Albemarle in a report on Friday, November 6th. Finally, Rothschild & Co Redburn dropped their price objective on shares of Albemarle from $100.00 to $86.00 in a research report on Wednesday, November 11th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $152.63.

Read Our Latest Stock Analysis on Albemarle

Albemarle Stock Performance

NYSE:ALB opened at $85.64 on Thursday. The stock has a market cap of $10.11 billion, a P/E ratio of 20.69, a PEG ratio of 0.55 and a beta of 1.34. The stock has a 50 day simple moving average of $101.19 and a 200 day simple moving average of $144.19. The company has a current ratio of 2.34, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21. Albemarle Corporation has a 1-year low of $85.22 and a 1-year high of $221.00.

Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The specialty chemicals company reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.05. Albemarle had a return on equity of 14.91% and a net margin of 10.40%. The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the previous year, the company posted ($0.19) EPS. The firm’s quarterly revenue was up 18.8% on a year-over-year basis. Research analysts anticipate that Albemarle Corporation will post 10.64 earnings per share for the current year.

Albemarle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be paid a $0.41 dividend. The ex-dividend date is Friday, December 18th. This represents a $1.64 annualized dividend and a dividend yield of 1.9%. Albemarle’s dividend payout ratio is 39.61%.

Albemarle Company Profile

(Free Report)

Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.

Read More

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.